IPO Preview | After two and a half years of cumulative losses of 1.2 billion, under heavy debt pressure, Jingfang Pharmaceutical "injured" ventures into the Hong Kong Stock Exchange.
Jingfang Pharmaceutical has submitted its listing application to the Hong Kong Stock Exchange.
Verastem Strengthens Financials and Partnerships for Drug Launch
Express News | Verastem Inc - Secures $150 Million Credit Facility and $7.5 Million Equity Investment
Express News | Verastem Oncology Announces Debt Refinancing With Oberland Capital and Strategic Commercialization Partnership With IQVIA to Support Potential Launch in Recurrent Kras Mutant Low-Grade Serous Ovarian Cancer in Mid-2025
Express News | Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
